Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis

Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a long-half life. This study investigated the efficacy of CERA for correcting anemia in Korean patients on dialysis. Patients (≥18 yr) who were not receiving any ESAs for more than 8 weeks were randomly assigned to either...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jieun, Joo, Kwon-Wook, Chin, Ho-Jun, Chae, Dong-Wan, Kim, Sung-Gyun, Kim, Soo Jin, Chung, Wookyung, Kim, Sejoong, Huh, Wooseong, Oh, Ha Young, Choi, Bum Soon, Yang, Chul-Woo, Kim, Suhnggwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890480/
https://www.ncbi.nlm.nih.gov/pubmed/24431909
http://dx.doi.org/10.3346/jkms.2014.29.1.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890480/
https://www.ncbi.nlm.nih.gov/pubmed/24431909
http://dx.doi.org/10.3346/jkms.2014.29.1.76

Ejemplares similares